CAUCASIAN;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
HISPANIC;
HUMAN;
MEDICAL RESEARCH;
NEGRO;
PRIORITY JOURNAL;
RACE;
RACE DIFFERENCE;
RACISM;
REVIEW;
UNITED STATES;
AFRICAN AMERICANS;
BIOLOGICAL MARKERS;
BIOMEDICAL RESEARCH;
CLINICAL TRIALS;
CONTINENTAL POPULATION GROUPS;
DRUG COMBINATIONS;
GENETIC PREDISPOSITION TO DISEASE;
HEART FAILURE, CONGESTIVE;
HUMANS;
HYDRALAZINE;
ISOSORBIDE DINITRATE;
PREJUDICE;
UNITED STATES;
VARIATION (GENETICS);
Institute of Medicine, MD: The National Academies Press;, Accessed 03/37/07
Institute of Medicine. Unequal treatment; Confronting Racial and Ethnic Disparities in Health Care. Landover, MD: The National Academies Press; 2002. www.nap.edu/catalog/10260.html. Accessed 03/37/07.
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325:303-310.